ProForma 2.0
validated simple linear
ALKRALKRCWTKSIPPRPCFNH
OSTI-2369
Aliases: OSTI-2369
Normalized sequence
ALKRALKRCWTKSIPPRPCFNH
22 amino acids
Release PepDiana-V1-20260620
42
Activity records
1
Source papers
37
Positive
5
Negative / threshold
Versioned scientific descriptors
No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.
Molecular weight
2623.1561 Da
Molecular formula
C118H192N38O26S2
Theoretical pI
11.017
Net charge at pH 7
5.8602
GRAVY
-0.7091
Instability index
44.7409
Aromaticity
0.0909
Topological polar surface area
1039.83 Ų
cLogP
-8.5068
Hydrogen-bond donors
39
Hydrogen-bond acceptors
35
Rotatable bonds
82
Method: PepDiana sequence/structure descriptor pipeline
Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6
Calculated: 2026-06-20T11:01:38.358971+00:00
Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200
ProForma 2.0
validated simple linear
ALKRALKRCWTKSIPPRPCFNH
HELM 2.0
validated simple linear
PEPTIDE1{A.L.K.R.A.L.K.R.C.W.T.K.S.I.P.P.R.P.C.F.N.H}$$$$V2.0
Canonical SMILES
validated
CCC(C)C(NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CS)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(C)N)C(C)O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(CS)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(N)=O)C(=O)NC(Cc1c[nH]cn1)C(=O)O
Isomeric SMILES
validated
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
Paper-level observations
Table 3: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739
Table 3: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739
Table 3: OSTI-2369 MIC 8 μM against E. coli BAA 2340
Table 3: OSTI-2369 MBC 8 μM against E. coli BAA 2340
Table 3: OSTI-2369 MIC 8 μM against E. coli NCTC 13846
Table 3: OSTI-2369 MBC 8 μM against E. coli NCTC 13846
Table 3: OSTI-2369 MIC 16 μM against P. aeruginosa ATCC CRM 9027
Table 3: OSTI-2369 MBC 16 μM against P. aeruginosa ATCC CRM 9027
Table 3: OSTI-2369 MIC 32 μM against K. pneumoniae ATCC CRM 43861
Table 3: OSTI-2369 MBC 32 μM against K. pneumoniae ATCC CRM 43861
Table 3: OSTI-2369 MIC 256 μM against A. baumannii BAA 747
Table 3: OSTI-2369 MBC 256 μM against A. baumannii BAA 747
Table 3: OSTI-2369 MIC >512 μM against S. aureus ATCC CRM 6538
Table 3: OSTI-2369 MIC >512 μM against E. faecium NCTC 12697
Table 3: OSTI-2369 MIC 16 μM against MRSA NCTC 12493
Table 3: OSTI-2369 MBC 16 μM against MRSA NCTC 12493
Table 3: OSTI-2369 MIC >512 μM against C. albicans ATCC 10231
Table 4: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 in 1% DMSO (control)
Table 4: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 in 1% DMSO (control)
Table 4: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 with FeCl3
Table 4: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 with FeCl3
Table 4: OSTI-2369 MIC 128 μM against E. coli ATCC CRM 8739 with CaCl2
Table 4: OSTI-2369 MBC 128 μM against E. coli ATCC CRM 8739 with CaCl2
Table 4: OSTI-2369 MIC 4 μM against E. coli ATCC CRM 8739 with NaCl
Table 4: OSTI-2369 MBC 4 μM against E. coli ATCC CRM 8739 with NaCl
Table 4: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 with KCl
Table 4: OSTI-2369 MBC 16 μM against E. coli ATCC CRM 8739 with KCl
Table 4: OSTI-2369 MIC 16 μM against E. coli ATCC CRM 8739 with MgCl2
Table 4: OSTI-2369 MBC 16 μM against E. coli ATCC CRM 8739 with MgCl2
Table 4: OSTI-2369 MIC 4 μM against E. coli ATCC CRM 8739 with NH4Cl
Table 4: OSTI-2369 MBC 4 μM against E. coli ATCC CRM 8739 with NH4Cl
Table 4: OSTI-2369 MIC 16 μM against E. coli ATCC CRM 8739 with Serum
Table 4: OSTI-2369 MBC 16 μM against E. coli ATCC CRM 8739 with Serum
Table 5: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 (Contrast)
Table 5: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 (Contrast)
Table 5: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 with 0.25 mg/mL trypsin
Table 5: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 with 0.25 mg/mL trypsin
Table 5: OSTI-2369 MIC 8 μM against E. coli ATCC CRM 8739 with 0.5 mg/mL trypsin
Table 5: OSTI-2369 MBC 8 μM against E. coli ATCC CRM 8739 with 0.5 mg/mL trypsin
Section 3.8: OSTI-2369 produced little haemolysis, less than 10% even at the highest concentrations (1-512 μM) against horse erythrocytes
Section 3.8: OSTI-2369 had minimal impact on HaCaT cell proliferation at 0.1-10 μM but reduced proliferation by more than 20% at 100 μM
Table 2: OSTI-2369 Trypsin Ki = 0.044 μM
Citation and release provenance
Cite this identity as PepDiana record PEPDIA-PLP-000138, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.
Record updated: 2026-06-22T07:14:26.229247+00:00